Eight years experience with liver transplantation in Rio Hortega hospital
| Autor: | E. Asensio-Diaz, D. Pacheco-Sanchez, P. Pinto-Fuentes, A. Barrera-Rebollo, F. Labarga-Rodríguez, B. Perez-Saborido, J.C. Sarmentero-Prieto, A. Anta-Román, G. Sánchez-Antolín, P. Rodríguez-Vielba |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male medicine.medical_specialty Cirrhosis Hepatitis C virus medicine.medical_treatment Liver transplantation medicine.disease_cause medicine Humans Aged Retrospective Studies Transplantation business.industry Mortality rate Incidence (epidemiology) Perioperative Middle Aged medicine.disease Thrombosis Surgery Liver Transplantation Spain Hepatocellular carcinoma Female business |
| Zdroj: | Transplantation proceedings. 43(3) |
| ISSN: | 1873-2623 |
| Popis: | Objectives We sought to evaluate our transplant series in light of the parameters outlined in the quality criteria established by the Spanish Hepatic Transplant Society (Sociedad Espanola de Trasplante Hepatico [SETH]). Methods We retrospectively analyzed 240 hepatic transplantations performed in 223 patients from November 2001 to December 2009. Results Among the series, 57% were in Child class C, 50% had cirrhosis without hepatocellular carcinoma, and 32% had this neoplasm. The most common cause for the illness was alcohol, followed by a virus, namely hepatitis C virus in 76% of cases. The average waiting list time was 45.14 days. The total graft ischemia averaged 460 minutes (range, 265–937). The 4.1% ( n = 10), incidence of an urgent retransplantation was mainly due to primary graft failure or arterial thrombosis. During the perioperative period the mortality rate was 2.5% ( n = 6) and the 1-month mortality rate was 6.6% ( n = 16). The raw survival rates at 1, 3, and 5 years after the operation are 85%, 78%, and 72%, respectively. Conclusion Our perioperative as well as the long-term results fall within the quality standards established by SETH. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect